Two developments over the past couple of months—one quiet and global and the other local but widespread—contain some glimpses of future changes once humanity comes to terms with coronavirus.
These changes might be short-lived, but will provide a view of an alternative future, both beautiful and ugly at the same time.
Convention demands grace take precedence over the unsightly. So, the good news first.A lot of hope has been pinned on a deal that the University of Oxford signed with UK-based pharmaceutical giant AstraZeneca for developing and manufacturing a coronavirus vaccine.
However, the move seems counter-intuitive. AstraZeneca is not big on vaccines; its closest competitor, GlaxoSmithKline, is the reigning champion, with proven vaccines.